Jonathan Aliota, MD
See Publications

Honors, Awards and Memberships

Publications

4862227 NMBVXFVC 1 alternatives-to-animal-experimentation 10 date desc Aliota 38854 https://www.texasheart.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22ANBCDZA2%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Fernandes%20et%20al.%22%2C%22parsedDate%22%3A%222012%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BFernandes%2C%20M.%20R.%2C%20Fish%2C%20R.%20D.%2C%20Canales%2C%20J.%20et%20al.%20%282012%29.%20Restoration%20of%20microcirculatory%20patency%20after%20myocardial%20infarction%3A%20results%20of%20current%20coronary%20interventional%20strategies%20and%20techniques.%20%26lt%3Bi%26gt%3BTex%20Heart%20Inst%20J%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B39%26lt%3B%5C%2Fi%26gt%3B%2C%20342%26%23x2013%3B350%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Restoration%20of%20microcirculatory%20patency%20after%20myocardial%20infarction%3A%20results%20of%20current%20coronary%20interventional%20strategies%20and%20techniques%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marlos%20R.%22%2C%22lastName%22%3A%22Fernandes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%20David%22%2C%22lastName%22%3A%22Fish%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%22%2C%22lastName%22%3A%22Canales%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%22%2C%22lastName%22%3A%22Aliota%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guilherme%20V.%22%2C%22lastName%22%3A%22Silva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emerson%20C.%22%2C%22lastName%22%3A%22Perin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Macarthur%20A.%22%2C%22lastName%22%3A%22Elayda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20M.%22%2C%22lastName%22%3A%22Wilson%22%7D%5D%2C%22abstractNote%22%3A%22We%20sought%20to%20evaluate%20the%20restoration%20of%20microcirculatory%20patency%20after%20primary%20percutaneous%20coronary%20intervention%20%28PCI%29%20in%20an%20unselected%20cohort%20of%20patients%20at%20a%20tertiary%20center.We%20retrospectively%20evaluated%20distributions%20of%20the%20Thrombolysis%20in%20Myocardial%20Infarction%20%28TIMI%29%20myocardial%20perfusion%20grade%20%28TMPG%29%20and%20the%20myocardial%20blush%20grade%20%28MBG%29%20in%20all%20primary%20PCI%20procedures%20performed%20at%20our%20institution%20during%202008.%20We%20defined%20optimal%20microvascular%20perfusion%20as%20simultaneous%20TMPG%203%20and%20MBG%203%20at%20procedure%26%23039%3Bs%20end.Ninety-nine%20patients%20%28mean%20age%2C%2061.5%20%5Cu00b1%2012.7%20yr%3B%2064%20men%29%20underwent%20primary%20PCI.%20Microvascular%20perfusion%20was%20optimal%20in%2069%20patients%20%2869.7%25%29%20and%20was%20associated%20with%20lower%20peaks%20of%20enzymes%20than%20those%20occurring%20in%20patients%20with%20suboptimal%20perfusion.%20When%20optimal%20microvascular%20perfusion%20was%20achieved%2C%20early%20spontaneous%20recanalization%20was%20more%20frequently%20observed%2C%20as%20expressed%20by%20a%20higher%20frequency%20of%20TIMI-3%20flow%20%2834.8%25%20vs%2010%25%3B%20P%3D0.006%29%2C%20TMPG%203%20%2826%25%20vs%203.3%25%3B%20P%3D0.004%29%2C%20and%20MBG%203%20%2824.6%25%20vs%203.3%25%3B%20P%3D0.004%29%20on%20the%20initial%20angiogram%20before%20primary%20PCI.%20A%20higher%20frequency%20of%20MBG%203%20%2850%25%20vs%2020%25%3B%20P%3D0.005%29%20was%20seen%20after%20initial%20recanalization%20in%20patients%20with%20optimal%20microvascular%20perfusion.%20Multiple%20regression%20analysis%20showed%20that%20MBG%20after%20initial%20recanalization%20and%20the%20use%20of%20drug-eluting%20stents%20were%20associated%20with%20optimal%20perfusion.Despite%20successful%20recanalization%20of%20the%20culprit%20coronary%20artery%2C%20optimal%20microvascular%20perfusion%20was%20achieved%20in%20less%20than%2075%25%20of%20the%20patients.%20Restoration%20of%20the%20microvasculature%20was%20associated%20with%20smaller%20infarcts.%20Procedure-related%20variables%20associated%20with%20suboptimal%20perfusion%20were%20unlikely%20to%20be%20causative.%22%2C%22date%22%3A%222012%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%221526-6702%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22YRK99JHR%22%2C%228HHBIBI6%22%2C%222K4N54U2%22%2C%22NMBVXFVC%22%2C%228PULYTSK%22%5D%2C%22dateModified%22%3A%222021-08-21T14%3A22%3A32Z%22%7D%7D%2C%7B%22key%22%3A%22TXPDBS6Y%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Munir%20et%20al.%22%2C%22parsedDate%22%3A%222011%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BMunir%2C%20M.%2C%20%26lt%3Bstrong%26gt%3BAliota%26lt%3B%5C%2Fstrong%26gt%3B%2C%20J.%2C%20Ahmed%2C%20A.%20et%20al.%20%282011%29.%20Sirolimus-eluting%20stents%20versus%20bare-metal%20stents%20in%20routine%20clinical%20use%3A%20a%20nonrandomized%20comparison.%20%26lt%3Bi%26gt%3BTex%20Heart%20Inst%20J%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B38%26lt%3B%5C%2Fi%26gt%3B%2C%20508%26%23x2013%3B515%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Sirolimus-eluting%20stents%20versus%20bare-metal%20stents%20in%20routine%20clinical%20use%3A%20a%20nonrandomized%20comparison%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Muhammad%22%2C%22lastName%22%3A%22Munir%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%22%2C%22lastName%22%3A%22Aliota%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amany%22%2C%22lastName%22%3A%22Ahmed%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anwarullah%22%2C%22lastName%22%3A%22Mohammed%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vei%20Vei%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Macarthur%20A.%22%2C%22lastName%22%3A%22Elayda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20M.%22%2C%22lastName%22%3A%22Wilson%22%7D%5D%2C%22abstractNote%22%3A%22Conflicting%20patient%20outcomes%20have%20been%20reported%20after%20the%20use%20of%20sirolimus-eluting%20stents%20or%20bare-metal%20stents.%20In%20this%20nonrandomized%20study%2C%20we%20examine%20the%20outcomes%20after%20placement%20of%20sirolimus-eluting%20versus%20bare-metal%20stents%20in%20an%20unselected%20population%20of%20patients%20who%20underwent%20percutaneous%20coronary%20revascularization.We%20used%20THIRD-base%2C%20a%20longitudinal%20data%20registry%20of%20patients%20who%20underwent%20revascularization%20at%20our%20institution%2C%20to%20compare%20demographics%20and%20outcomes%20in%20patients%20treated%20with%20a%20sirolimus-eluting%20or%20bare-metal%20stent%20from%20January%202001%20through%20June%202006.%20Outcome%20measures%20included%20major%20acute%20coronary%20and%20cerebral%20events%20at%2030%20days%2C%20target-vessel%20failure%20at%209%20months%20and%20at%203%20years%2C%20and%20stent%20thrombosis.%20Target-vessel%20failure%20was%20defined%20as%20the%20composite%20of%20all-cause%20death%2C%20recurrent%20myocardial%20infarction%20in%20the%20treated%20vessel%20distribution%2C%20and%20target-vessel%20revascularization.%20Logistic%20regression%20and%20Cox%20proportional%20regression%20models%20were%20used%20to%20determine%20the%20predictors%20of%20outcome.Of%20the%206%2C425%20patients%20analyzed%2C%202%2C581%20patients%20%2840.2%25%29%20received%20only%20sirolimus-eluting%20stents%2C%20and%203%2C844%20patients%20%2859.8%25%29%20received%20only%20bare-metal%20stents.%20Early%20major%20acute%20coronary%20and%20cerebral%20events%20and%20stent%20thrombosis%20at%2030%20days%20and%209%20months%20were%20similar%20in%20both%20groups.%20Target-vessel%20failure%20was%20less%20frequent%20in%20sirolimus-eluting%20stent%20patients%20than%20in%20bare-metal%20stent%20patients%20at%209%20months%20%284.84%25%20vs%2011.81%25%2C%20P%20%26lt%3B%200.0001%29%20and%20at%203%20years%20%2829%25%20vs%2032%25%2C%20P%20%26lt%3B%200.0001%29.Use%20of%20sirolimus-eluting%20stents%20improved%20target-vessel%20failure%20survival%20at%209%20months%20and%20at%203%20years.%20Late%20adverse%20events%20were%20determined%20by%20known%20risk%20factors%20for%20atherosclerosis%2C%20not%20by%20stent%20type.%22%2C%22date%22%3A%222011%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%221526-6702%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22DT56KN4G%22%2C%22NMBVXFVC%22%5D%2C%22dateModified%22%3A%222021-08-21T14%3A22%3A37Z%22%7D%7D%5D%7D
Fernandes, M. R., Fish, R. D., Canales, J. et al. (2012). Restoration of microcirculatory patency after myocardial infarction: results of current coronary interventional strategies and techniques. Tex Heart Inst J 39, 342–350
Munir, M., Aliota, J., Ahmed, A. et al. (2011). Sirolimus-eluting stents versus bare-metal stents in routine clinical use: a nonrandomized comparison. Tex Heart Inst J 38, 508–515